ADAMTS20
Basic information
Region (hg38): 12:43353866-43552203
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAMTS20 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 93 | 10 | 104 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 93 | 14 | 2 |
Variants in ADAMTS20
This is a list of pathogenic ClinVar variants found in the ADAMTS20 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-43356546-A-C | not specified | Uncertain significance (Dec 04, 2023) | ||
12-43356572-T-C | ADAMTS20-related condition | Likely benign (Aug 11, 2024) | ||
12-43369341-T-C | ADAMTS20-related condition | Likely benign (Aug 11, 2024) | ||
12-43369344-A-C | not specified | Likely benign (Mar 29, 2022) | ||
12-43369353-T-C | not specified | Uncertain significance (Mar 31, 2024) | ||
12-43375382-T-C | not specified | Uncertain significance (Oct 03, 2022) | ||
12-43375441-A-G | not specified | Uncertain significance (Jun 22, 2024) | ||
12-43375448-C-G | not specified | Uncertain significance (Jul 20, 2022) | ||
12-43375460-C-G | not specified | Uncertain significance (May 10, 2024) | ||
12-43376063-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
12-43376118-G-C | not specified | Uncertain significance (Jan 18, 2022) | ||
12-43376330-C-T | not specified | Uncertain significance (Oct 24, 2023) | ||
12-43376551-C-A | not specified | Uncertain significance (Jun 13, 2022) | ||
12-43376601-G-T | not specified | Uncertain significance (Nov 17, 2023) | ||
12-43376619-C-G | not specified | Uncertain significance (Nov 09, 2021) | ||
12-43376634-A-G | not specified | Uncertain significance (Aug 10, 2021) | ||
12-43377445-C-T | not specified | Uncertain significance (Mar 01, 2024) | ||
12-43377512-G-A | Likely benign (Oct 01, 2022) | |||
12-43377523-T-C | not specified | Uncertain significance (Jan 10, 2022) | ||
12-43383583-A-G | not specified | Uncertain significance (Aug 22, 2023) | ||
12-43383590-T-G | not specified | Uncertain significance (Jul 16, 2021) | ||
12-43383623-G-C | not specified | Uncertain significance (Mar 02, 2023) | ||
12-43383658-A-G | not specified | Uncertain significance (May 09, 2024) | ||
12-43383691-C-T | not specified | Likely benign (Mar 05, 2024) | ||
12-43383711-C-G | not specified | Uncertain significance (Apr 20, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADAMTS20 | protein_coding | protein_coding | ENST00000389420 | 39 | 198056 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.45e-38 | 0.816 | 125219 | 0 | 391 | 125610 | 0.00156 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.686 | 1038 | 978 | 1.06 | 0.0000485 | 12478 |
Missense in Polyphen | 392 | 397.32 | 0.98662 | 4993 | ||
Synonymous | 0.250 | 326 | 332 | 0.983 | 0.0000166 | 3412 |
Loss of Function | 3.04 | 77 | 112 | 0.690 | 0.00000620 | 1366 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00345 | 0.00342 |
Ashkenazi Jewish | 0.00338 | 0.00338 |
East Asian | 0.00245 | 0.00234 |
Finnish | 0.000324 | 0.000324 |
European (Non-Finnish) | 0.00152 | 0.00128 |
Middle Eastern | 0.00245 | 0.00234 |
South Asian | 0.00244 | 0.00226 |
Other | 0.00158 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in tissue-remodeling process occurring in both normal and pathological conditions. May have a protease- independent function in the transport from the endoplasmic reticulum to the Golgi apparatus of secretory cargos, mediated by the GON domain.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;O-glycosylation of TSR domain-containing proteins;O-linked glycosylation
(Consensus)
Recessive Scores
- pRec
- 0.0930
Intolerance Scores
- loftool
- 0.850
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.58
Haploinsufficiency Scores
- pHI
- 0.145
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.385
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0458
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adamts20
- Phenotype
- limbs/digits/tail phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); pigmentation phenotype; embryo phenotype; cellular phenotype; craniofacial phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- proteolysis;positive regulation of signal transduction;extracellular matrix organization;negative regulation of apoptotic process;positive regulation of melanocyte differentiation
- Cellular component
- extracellular space;collagen-containing extracellular matrix
- Molecular function
- metalloendopeptidase activity;zinc ion binding